CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 94 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $107 | -58.2% | 48 | 0.0% | 0.00% | – |
| Q1 2024 | $256 | +260.6% | 48 | 0.0% | 0.00% | – |
| Q4 2023 | $71 | +6.0% | 48 | 0.0% | 0.00% | – |
| Q3 2023 | $67 | -5.6% | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $71 | -10.1% | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $79 | +17.9% | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $67 | – | 48 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 48 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,845,164 | $26,183,000 | 24.69% |
| Corriente Advisors, LLC | 910,000 | $12,913,000 | 6.55% |
| Opaleye Management Inc. | 1,731,600 | $24,571,000 | 4.80% |
| VR Adviser, LLC | 1,271,985 | $18,049,000 | 3.53% |
| Soleus Capital Management, L.P. | 281,819 | $3,999,000 | 2.12% |
| Blue Rock Advisors, LLC | 106,481 | $1,511,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 305,900 | $4,341,000 | 1.18% |
| EAM Investors, LLC | 332,900 | $4,724,000 | 1.12% |
| RA Capital Management | 3,290,000 | $46,685,000 | 0.85% |
| EAM Global Investors LLC | 140,231 | $1,990,000 | 0.73% |